DE69331825D1 - Zusammensetzungen und methoden der inhibition der beta-proteinfunktion - Google Patents
Zusammensetzungen und methoden der inhibition der beta-proteinfunktionInfo
- Publication number
- DE69331825D1 DE69331825D1 DE69331825T DE69331825T DE69331825D1 DE 69331825 D1 DE69331825 D1 DE 69331825D1 DE 69331825 T DE69331825 T DE 69331825T DE 69331825 T DE69331825 T DE 69331825T DE 69331825 D1 DE69331825 D1 DE 69331825D1
- Authority
- DE
- Germany
- Prior art keywords
- inhibition
- compositions
- methods
- protein function
- beta protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
- C07K14/8121—Serpins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/44—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving esterase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4709—Amyloid plaque core protein
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/81—Protease inhibitors
- G01N2333/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- G01N2333/811—Serine protease (E.C. 3.4.21) inhibitors
- G01N2333/8121—Serpins
- G01N2333/8125—Alpha-1-antitrypsin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/20—Screening for compounds of potential therapeutic value cell-free systems
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
- G01N2800/2821—Alzheimer
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- General Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Toxicology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/819,361 US5338663A (en) | 1990-08-24 | 1992-01-13 | Method of identifying inhibitors of β-protein esterase activity |
PCT/US1993/000325 WO1993015112A2 (en) | 1992-01-13 | 1993-01-13 | COMPOUNDS AND METHODS FOR INHIBITING β-PROTEIN FUNCTION |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69331825D1 true DE69331825D1 (de) | 2002-05-23 |
DE69331825T2 DE69331825T2 (de) | 2002-11-28 |
Family
ID=25227943
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69331825T Expired - Fee Related DE69331825T2 (de) | 1992-01-13 | 1993-01-13 | Zusammensetzungen und methoden der inhibition der beta-proteinfunktion |
Country Status (5)
Country | Link |
---|---|
US (1) | US5338663A (de) |
EP (1) | EP0623146B1 (de) |
JP (1) | JPH07509447A (de) |
DE (1) | DE69331825T2 (de) |
WO (1) | WO1993015112A2 (de) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5780587A (en) * | 1990-08-24 | 1998-07-14 | President And Fellows Of Harvard College | Compounds and methods for inhibiting β-protein filament formation and neurotoxicity |
US5506097A (en) * | 1990-08-24 | 1996-04-09 | President And Fellows Of Harvard College | Method for inhibiting β-protein enzymatic activity |
US6180771B1 (en) * | 1993-12-08 | 2001-01-30 | Immulogic Pharmaceutical Corp. | Nucleic acids encoding a house dust mite allergen, Der p III, and uses therefor |
US6303567B1 (en) | 1995-03-14 | 2001-10-16 | Praecis Pharmaceuticals, Inc . | Modulators of β-amyloid peptide aggregation comprising D-amino acids |
US5854215A (en) * | 1995-03-14 | 1998-12-29 | Praecis Pharmaceuticals Incorporated | Modulators of β-amyloid peptide aggregation |
US5817626A (en) * | 1995-03-14 | 1998-10-06 | Praecis Pharmaceuticals Incorporated | Modulators of beta-amyloid peptide aggregation |
US5854204A (en) * | 1995-03-14 | 1998-12-29 | Praecis Pharmaceuticals, Inc. | Aβ peptides that modulate β-amyloid aggregation |
CA2220551A1 (en) * | 1995-05-12 | 1996-11-14 | Schering Corporation | Surface plasmon resonance based enzymatic assay |
US5985242A (en) * | 1995-10-27 | 1999-11-16 | Praecis Pharmaceuticals, Inc. | Modulators of β-amyloid peptide aggregation comprising D-amino acids |
US6277826B1 (en) * | 1996-08-27 | 2001-08-21 | Praecis Pharmaceuticals, Inc. | Modulators of β-amyloid peptide aggregation comprising D-amino acids |
US6017723A (en) * | 1998-03-27 | 2000-01-25 | Long Island Jewish Medical Center | Method for isolating inhibitors of protease activity |
NZ514414A (en) * | 1999-03-04 | 2004-02-27 | Praecis Pharm Inc | Modulators of beta-amyloid peptide aggregation comprising D-amino acids |
AU2001253597A1 (en) * | 2000-04-12 | 2001-10-30 | Minerva Biotechnologies Corporation | Treatment of neurodegenerative disease |
US20080063636A1 (en) * | 2004-10-06 | 2008-03-13 | Hiroshi Mori | Variant Amyloid Protein |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4273866A (en) * | 1979-02-05 | 1981-06-16 | Abbott Laboratories | Ligand analog-irreversible enzyme inhibitor conjugates and methods for use |
US4303592A (en) * | 1980-01-09 | 1981-12-01 | Center For Blood Research, Inc. | Amidinophenylmethylsulfonylfluoride |
JPS56128774A (en) * | 1980-03-14 | 1981-10-08 | Microbial Chem Res Found | New physiologically active substance ebelactone and its preparation |
US5187153A (en) * | 1986-11-17 | 1993-02-16 | Scios Nova Inc. | Methods of treatment using Alzheimer's amyloid polypeptide derivatives |
US5079336A (en) * | 1989-06-23 | 1992-01-07 | The Trustees Of The University Of Pennsylvania | α-1-antichymotrypsin, analogues and methods of production |
WO1991013904A1 (en) * | 1990-03-05 | 1991-09-19 | Cephalon, Inc. | Chymotrypsin-like proteases and their inhibitors |
EP0546084A4 (en) * | 1990-08-17 | 1994-10-19 | Univ Boston | Proteases causing abnormal degradation of amyloid -g(b)-protein precursor |
WO1992003474A1 (en) * | 1990-08-24 | 1992-03-05 | President And Fellows Of Harvard College | METHOD OF INTERFERING WITH FORMATION OF α-ANTICHYMOTRYPSIN-β-PROTEIN COMPLEX AND SYNTHETIC PEPTIDES FOR USE THEREIN |
-
1992
- 1992-01-13 US US07/819,361 patent/US5338663A/en not_active Expired - Lifetime
-
1993
- 1993-01-13 JP JP5513265A patent/JPH07509447A/ja active Pending
- 1993-01-13 DE DE69331825T patent/DE69331825T2/de not_active Expired - Fee Related
- 1993-01-13 EP EP93903485A patent/EP0623146B1/de not_active Expired - Lifetime
- 1993-01-13 WO PCT/US1993/000325 patent/WO1993015112A2/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
EP0623146A1 (de) | 1994-11-09 |
WO1993015112A3 (en) | 1993-09-02 |
WO1993015112A2 (en) | 1993-08-05 |
DE69331825T2 (de) | 2002-11-28 |
EP0623146B1 (de) | 2002-04-17 |
US5338663A (en) | 1994-08-16 |
JPH07509447A (ja) | 1995-10-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI944885A (fi) | Tölkin perusosa | |
FI935223A (fi) | Rake-mottagare med selektiv kombinering av straolar | |
FI951197A (fi) | Mikrobisidiset koostumukset ja menetelmät | |
FI89097C (fi) | Matningsbomanordning vid bergsborr | |
DE69223984D1 (de) | Zusammensetzungen von difluormethan und tetrafluorethan | |
NO933836D0 (no) | Utblaasningssikring av avstengertypen | |
DE69331825D1 (de) | Zusammensetzungen und methoden der inhibition der beta-proteinfunktion | |
FI931408A0 (fi) | Anordning foer fraesning av amorfiska staolremsor | |
FI934519A (fi) | Foerfarande foer finfoerdelning av inmatat material vid en kvackningsprocess med flytbaeddskatalysator | |
NO930574L (no) | Fremgangsmaate for fremstilling av desfluran | |
BR8905444A (pt) | Composicoes e aplicacao | |
NO940190D0 (no) | Anvendelse av x-ketoglutarat | |
NO930470D0 (no) | Framgangsmaate for framstilling av ferrosilisum-legering | |
DE69217904D1 (de) | Zusammensetzung | |
FI910207A (fi) | Fungisidisia vaikuttavien aineiden yhdistelmiä | |
ITMI912654A1 (it) | Combinazione di estrusore-calandra | |
DK0599461T3 (da) | Hærdelige sammensætninger | |
FI925493A0 (fi) | Rumselementsystem foer ersaettning av vaotutrymmen med tillfaelligutrymmeni samband med byggnadsarbeten | |
FI932658A0 (fi) | Foerfarande foer framstaellning av viskosfibrer med bandformade tvaersnitt | |
KR930021041U (ko) | 식기세척기의 상판과 케이스의 결합수단 | |
KR930026760U (ko) | Tvcr의 개선된 구성 | |
NO930459D0 (no) | Fremgangsmaate for fremstilling av plateformede konstruksjonselemente | |
LV10073A (lv) | Skidinataju absolutizesanas panemiens | |
FI921063A (fi) | Foerfarande foer reparering av en stolpes roetskadade nebre aenda i en byggnad med traestomme | |
FI930088A0 (fi) | Urinsamlare foer underlaettande av provtagning fraon barn |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8328 | Change in the person/name/address of the agent |
Free format text: G. KOCH UND KOLLEGEN, 80339 MUENCHEN |
|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |